Premier, Inc. (PINC) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals strong financial performance, with increased guidance for EBITDA and EPS, and a strategic partnership with Epic. The Q&A highlights growth in advisory services and stable supply chain conditions. Despite some vague responses, the company's strategic initiatives and optimistic guidance suggest a positive stock movement. The market cap indicates a moderate reaction, leading to a prediction of a positive stock price movement (2% to 8%) over the next two weeks.
Key Financial Performance
Total full year revenue $986 million, $11 million above the midpoint of the guidance range. Reasons for the increase include better-than-anticipated performance in the Supply Chain Services segment, driven by better contract penetration and ramp-up of new member spend.
Adjusted EPS $1.54, $0.11 above the high end of the guidance range. This was due to better-than-expected revenue in the Supply Chain Services segment and a lower share count.
Net revenue (Q4) $258 million, increased 1% sequentially but declined year-over-year. The decline was largely driven by higher fee share from contract renewals, which are now mostly completed.
GAAP net income and EPS (Q4) $18 million or $0.22 per share, decreased from the prior year period. The decrease was mainly due to lower revenue in the current year quarter.
Adjusted EBITDA (Q4) $71 million, flat sequentially with a margin of 27.6%. This was better than expected due to high-margin flow-through from revenue outperformance in Supply Chain Services.
Free cash flow (FY 2025) $181 million, decreased $48 million year-over-year. The decrease was mainly due to higher performance-related compensation payments and the timing of payments to OMNIA, partially offset by cash received from a derivative lawsuit settlement and a dividend distribution from a minority investment.
Gross administrative fees (Supply Chain Services) Grew over 3% in fiscal year 2025. This growth was driven by higher contract penetration with existing members and onboarding of new members.
Other Supply Chain Services revenue Driven by 17% growth in the supply chain co-management business and 15% growth in the digital supply chain business. Reasons include new engagements with members and further expansion of solutions to providers and suppliers.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Acquisition of IllumiCare: Premier acquired IllumiCare to enhance real-time insights at the point of care, leveraging AI capabilities. This complements their clinical decision support offerings and expands their addressable market.
Expansion in GPO pharmacy and food portfolios: Premier's pharmacy and food portfolios are attracting non-member organizations, serving as entry points for broader engagement and delivering steady growth.
Supply Chain Services performance: The segment exceeded expectations with increased contract penetration and onboarding of new members. Growth was observed in MedSurg, pharmacy, food, and purchase services categories.
Cost structure optimization: Premier reduced operating expenses by $40 million annually and plans to reinvest savings into growth areas.
Focus on long-term value creation: Premier is helping health systems move beyond short-term cost containment to structural changes for operational resilience and long-term value.
Advisory business momentum: Premier signed four large advisory deals and is building a robust pipeline, indicating enterprise-wide transformation demand.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Financial pressures on member hospitals and health systems: Mounting financial pressures, including reimbursement cuts, are forcing health systems to rethink cost structures and long-term sustainability, posing challenges to Premier's member base and potentially impacting demand for services.
Reimbursement uncertainty and cost pressures: Ongoing cost pressures and reimbursement uncertainty are driving demand for margin improvement solutions, but also create risks for Premier's financial performance and member engagement.
Tariff impacts: Potential tariff impacts could disrupt supply chain operations and increase costs, affecting the company's Supply Chain Services segment.
Contract renewals and fee share increases: Higher fee share from contract renewals is impacting revenue growth, with fee share expected to stabilize in the high 60% range, creating short-term financial challenges.
Performance Services segment rebuilding: The Performance Services segment is still rebuilding its sales funnel, with lower enterprise license revenue and a need to regain double-digit growth, indicating operational challenges.
Transition and wind-down of Contigo Health assets: The ongoing transition and wind-down of Contigo Health assets may create temporary disruptions and financial impacts.
Economic uncertainties: Broader economic uncertainties could impact member hospitals' financial health and their ability to engage with Premier's services.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Projections for FY 2026: Total net revenue is expected to range between $940 million and $1 billion. Segment-wise, Supply Chain Services revenue is projected to be $590 million to $620 million, and Performance Services revenue is expected to be $350 million to $380 million.
Adjusted EBITDA and EPS for FY 2026: Adjusted EBITDA is projected to range from $230 million to $245 million, while adjusted EPS is expected to be between $1.33 and $1.43.
Free Cash Flow Conversion: Free cash flow conversion is anticipated to be in the range of 70% to 80% for fiscal year 2026.
Operating Expenses: Operating expenses are expected to slightly decrease year-over-year in fiscal year 2026, despite reinvestments in faster-growing areas of the business.
Quarterly Guidance for Q1 FY 2026: Total net revenue is expected to range between $230 million and $245 million. Adjusted EBITDA is projected to be $45 million to $50 million, and adjusted EPS is expected to range from $0.27 to $0.32.
Growth Expectations for FY 2027: The company expects to return to positive growth for total net revenue, adjusted EBITDA, and adjusted EPS in fiscal year 2027.
Advisory Business Growth: The advisory business is expected to return to double-digit growth in fiscal year 2026, supported by a robust pipeline of opportunities and recent large contract wins.
Supply Chain Services Growth Opportunities: Growth opportunities are identified in the supply chain co-management business and digital supply chain business, which grew 17% and 15%, respectively, in fiscal year 2025. These areas are expected to continue growing in fiscal year 2026 and beyond.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Cash Dividend: Premier, Inc. continued to return meaningful capital to stockholders through its quarterly cash dividend, totaling $77 million in fiscal year 2025, representing a nearly 4% dividend yield.
Accelerated Share Repurchase Program: Premier, Inc. completed a $200 million accelerated share repurchase program in mid-August 2025, bringing the total amount of common stock repurchased to $800 million under its $1 billion authorization, which expired on June 30, 2025.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What changes in customer buying behavior were observed in the Supply Chain Services segment during the quarter?
A:There were no significant changes or pull forward in buying behavior due to potential tariffs. Some regional increases were observed, but they were not significant.
Q:What is driving the momentum in the advisory business?
A:The momentum is driven by market dynamics such as cost pressures, labor issues, and potential Medicaid cuts. Premier has a strong team led by Dave Zito, who has a history of success in advisory. The company has signed four large deals recently, and its trusted brand, breadth of resources, and technology enablement are key factors.
Q:Can you provide color on the cadence of admin fee renewal and the underlying admin fee share growth assumption for fiscal year '26?
A:Gross administrative fees grew 3% on a full-year basis in fiscal year '25, with growth in all four quarters. For fiscal year '26, the company expects a 4% growth in gross administrative fees and fee share to increase to the mid-60% range by the end of the year. The company will complete most of the 2020 restructured contracts by the end of fiscal year '26.
Q:What is the expected segment EBITDA level for fiscal year '26?
A:The company expects EBITDA margin expansion in the Performance Services business due to the ramp-up of Advisory Services. However, EBITDA margins in Supply Chain Services are expected to decline due to ongoing fee share resets. Overall, the company anticipates growth across key financial metrics by fiscal year '27.
Q:What is the size and expected financial impact of the IllumiCare acquisition?
A:IllumiCare is expected to generate $8-10 million in revenue in fiscal year '26 and be breakeven on the bottom line. It is anticipated to drive double-digit growth moving forward and integrate well with Premier's Stanson Health capabilities.
Q:Are there any observed divergences in food purchasing patterns versus MedSurg purchasing patterns?
A:No significant divergences were observed. The food program is used as a strategic entry point into accounts and continues to grow and provide value to health systems.
Q:How big is the advisory business within Performance Services, and what is its expected growth in fiscal year '26?
A:The advisory business is roughly $50-100 million in size and is expected to grow by at least 25% in fiscal year '26, driven by four large contracts and a robust pipeline of opportunities.
Q:How does the TRA impact fiscal year '26 free cash flow guidance?
A:The TRA benefit of $100 million is included in the free cash flow guidance. However, other one-time items in fiscal year '25 offset this benefit, resulting in flat free cash flow year-over-year.
Q:Was there any forward buying or services activity due to tariffs?
A:No significant forward buying was observed due to tariffs. The company has a member-led contracting process that minimizes the impact of tariffs, and the market remains stable.
Q:What needs to happen in fiscal year '27 for revenue and EBITDA to increase?
A:Growth in enterprise license agreements, advisory services, and clinical decision support businesses is expected. Supply Chain Services is anticipated to see continued growth in gross administrative fees and reduced fee share headwinds.
Q:Did the client termination payment take place in Q4, and what was its size?
A:Yes, the client termination payment took place in Q4, and its size was consistent with the $15 million guidance increase for Supply Chain Services provided earlier.
Q:What is the magnitude of headcount additions in the advisory business, and how long do they take to ramp up?
A:The company has added roughly 10 senior leaders and plans to add about 20 more. New hires are deployed immediately to project work, so ramp-up is quick.
Q:What is the demand for tech in Performance Services post-July 4?
A:There is significant interest in clinical decision support capabilities, such as prior authorization and clinical coding. The company continues to expand these capabilities to meet market demand.
Q:What is the difference between consulting and advisory?
A:Consulting and advisory are interchangeable terms. They involve strategic and operational transformation of businesses, focusing on areas like workforce, supplies, clinical delivery, and revenue cycle.
Q:What updates are there on the life sciences or pharma support businesses?
A:The life sciences business is performing as expected and is anticipated to be a growth area in fiscal year '26 and beyond.
Q:Review of Unclear Management Responses
A:Management avoided providing specific segment guidance for EBITDA levels and used vague language when discussing the impact of tariffs and the cadence of admin fee renewals. Additionally, they did not provide detailed revenue or EBITDA profiles for certain business areas, such as life sciences.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Allen Lutz
Baird Co
Bank Research
BofA Securities
CEO Director
CFO Chief
Canaccord Genuity
Chain Services
Clark Leerink
Close Canaccord
Co Incorporated
Co Research
Coldwell Baird
Coleman CFO
Collamer Close
Conference Instructions
Conference speaker
Corp Research
Eric
Full Conference
LLC
Premier Full
Research Division
Services segment
Supply Chain
change
expertise
momentum
need
point
portfolio
pressure
reimbursement
support
term value
PINC Transcript
Premier, Inc. (PINC) Q4 2025 Earnings Call Transcript
Positive8-19
The earnings call reveals strong financial performance, with increased guidance for EBITDA and EPS, and a strategic partnership with Epic. The Q&A highlights growth in advisory services and stable supply chain conditions. Despite some vague responses, the company's strategic initiatives and optimistic guidance suggest a positive stock movement. The market cap indicates a moderate reaction, leading to a prediction of a positive stock price movement (2% to 8%) over the next two weeks.
Premier, Inc. (PINC) Q3 2025 Earnings Call Transcript
Unknown5-6
The earnings call presents a mixed picture: strong financial metrics with increased adjusted EPS and EBITDA, but lower net revenue and challenges in Performance Services. The Q&A highlights concerns about rising costs, tariffs, and workforce shortages. Positive factors include a share repurchase program and dividend yield, but these are offset by uncertainties in revenue guidance and macroeconomic pressures. Given the company's market cap and the balanced positive and negative elements, a neutral stock price movement is expected over the next two weeks.
Premier, Inc. (NASDAQ:PINC) Q2 2025 Earnings Call Transcript
Unknown2-5
The earnings call presents a mixed picture: strong shareholder returns via buybacks and dividends, but financials show declining revenue and a net loss due to impairment charges. The Q&A highlights resilience in administrative fees and supply chain strategies but also reveals uncertainties regarding tariffs and consulting services. Given the stable guidance and mixed financial performance, the stock is likely to remain neutral, with potential slight fluctuations due to market sentiment.
Premier, Inc. (PINC) Q1 2025 Earnings Call Transcript
Unknown11-5
The earnings call indicates mixed signals: financial performance declined YoY, but there was a notable gain from a lawsuit settlement. The company announced a significant share repurchase and dividend payout, which are positive. However, management's vague responses on certain issues during the Q&A, coupled with an 8% revenue decline, suggest uncertainty. The market cap indicates a moderate reaction, resulting in a neutral stock price prediction.
PINC Slides
PINC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
